Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study

International Journal of Reproductive BioMedicine

Volumn 16, Issue 1, 2018, Pages 9-18

  Aflatoonian, Abbas ^a   Mansoori Torshizi, Mahnaz ^b   Mojtahedi, Maryam Farid ^c   Aflatoonian, Behrouz ^a   Khalili, Mohammaad Ali ^a   Amir Arjmand, Mohammad Hossein ^d   Soleimani, Mehrdad ^a   Aflatoonian, Nastaran ^d   Oskouian, Homa ^e   Tabibnejad, Nasim ^a   Humaidan, Peter ^f  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Assisted Reproduction Technology   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IVF Unit   (Iran)

^e Armaghan Infertility and IVF Clinic   (Iran)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

Fresh; Fresh embryo transfer; Frozen thawed embryo transfer; GnRH antagonist; GnRHa trigger; OHSS; Reproductive Outcome

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL VALERATE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; FEMALE; HUMAN; IN VITRO FERTILIZATION; INFERTILITY; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; TRANSVAGINAL ECHOGRAPHY; TWIN PREGNANCY;

EID: 85047872485     PISSN: 24764108     EISSN: 24763772     Source Type: Journal    
DOI: 10.29252/ijrm.16.1.9     Document Type: Article

References (30)

1. Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D’Hooghe T, Castilla JA, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHREdagger. Hum Reprod 2014; 29: 2099-2113.
2. DiLuigi AJ, Engmann L, Schmidt DW, Maier DB, Nulsen JC, Benadiva CA. Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting. Fertil Steril 2010; 94: 1111-1114.
3. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 2008; 89: 84-91.
4. Engmann L, Siano L, Schmidt D, Nulsen J, Maier D, Benadiva C. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS. Reprod Biomed Online 2006; 13: 639-644.
5. Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study. Fertil Steril 2011; 95: 2029-2033.
6. Humaidan P, Alsbjerg B. GnRHa trigger for final oocyte maturation: is HCG trigger history? Reprod Biomed Online 2014; 29: 274-280.
7. Humaidan P, Kol S, Papanikolaou EG; Copenhagen GnRH Agonist Triggering Workshop Group. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 2011; 17: 510-524.
8. Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, et al. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum Reprod 2013; 28: 2511-2521.
9. Humaidan P, Westergaard LG, Mikkelsen AL, Fukuda M, Yding Andersen C. Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin. Fertil Steril 2011; 95: 2034-2038.
10. Leth-Moller K, Hammer Jagd S, Humaidan P. The Luteal Phase after GnRHa Trigger- Understanding An Enigma. Int J Fertil Steril 2014; 8: 227-234.
11. Imbar T, Kol S, Lossos F, Bdolah Y, Hurwitz A, Haimov-Kochman R. Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in highrisk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support. Hum Reprod 2012; 27: 753-759.
12. Humaidan P. Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. Reprod Biomed Online 2009; 18: 630-634.
13. Humaidan P, Bungum L, Bungum M, Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006; 13: 173-178.
14. Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropinreleasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 2010; 93: 847-854.
15. Davenport MJ, Vollenhoven B, Talmor AJ. Gonadotropin-Releasing Hormone-Agonist Triggering and a Freeze-All Approach: The Final Step in Eliminating Ovarian Hyperstimulation Syndrome? Obstet Gynecol Surv 2017; 72: 296-308.
16. Roque M, Valle M, Kostolias A, Sampaio M, Geber S. Freeze-all cycle in reproductive medicine: current perspectives. JBRA Assist Reprod 2017; 21: 49-53.
17. Roque M. Freeze-all policy: is it time for that? J Assist Reprod Genet 2015; 32: 171-176.
18. Aflatoonian A, Karimzadeh Maybodi MA, Aflatoonian N, Tabibnejad N, Amir-Arjmand MH, Soleimani M, et al. Perinatal outcome in fresh versus frozen embryo transfer in ART cycles. Int J Reprod Biomed 2016; 14: 167-172.
19. Fritz MA SL. Clinical Gynecologic Endocrinology and Infertility. 8th Ed. Lipincott Williams & Wilkins; 2011: 1322-1323.
20. Huang CY, Shieh ML, Li HY. The benefit of individualized low-dose hCG support for high responders in GnRHa-triggered IVF/ICSI cycles. J Chin Med Assoc 2016; 79: 387-393.
21. Kol S, Humaidan P. GnRH agonist triggering: recent developments. Reprod Biomed Online 2013; 26: 226-230.
22. Datta AK, Eapen A, Birch H, Kurinchi-Selvan A, Lockwood G. Retrospective comparison of GnRH agonist trigger with HCG trigger in GnRH antagonist cycles in anticipated high-responders. Reprod Biomed Online 2014; 29: 552-558.
23. Radesic B, Tremellen K. Oocyte maturation employing a GnRH agonist in combination with lowdose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates. Hum Reprod 2011; 26: 3437-3442.
24. Haahr T, Roque M, Esteves SC, Humaidan P. GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Metaanalysis. Front Endocrinol 2017; 8: 116.
25. Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev 2014: CD008046.
26. Krishna D, Dhoble S, Praneesh G, Rathore S, Upadhaya A, Rao K. Gonadotropinreleasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial. J Hum Reprod Sci 2016; 9: 164-172.
27. Vlaisavljevic V, Kovacic B, Knez J. Cumulative live birth rate after GnRH agonist trigger and elective cryopreservation of all embryos in high responders. Reprod Biomed Online 2017; 35: 42-48.
28. Borges E Jr., Braga DP, Setti AS, Vingris LS, Figueira RC, Iaconelli A Jr. Strategies for the management of OHSS: Results from freezing-all cycles. JBRA Assist Reprod 2016; 20: 8-12.
29. Aflatoonian A, Mansoori Moghaddam F, Mashayekhy M, Mohamadian F. Comparison of early pregnancy and neonatal outcomes after frozen and fresh embryo transfer in ART cycles. J Assist Reprod Genet 2010; 27: 695-700.
30. Belva F, Bonduelle M, Roelants M, Verheyen G, Van Landuyt L. Neonatal health including congenital malformation risk of 1072 children born after vitrified embryo transfer. Hum Reprod 2016; 31: 1610-1620.